Benefit of cervical screening at different ages: evidence from the UK audit of screening histories View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-07-01

AUTHORS

P Sasieni, J Adams, J Cuzick

ABSTRACT

While most experts agree that cervical screening is effective, there remains controversy over the most appropriate screening interval. Annual screening is common in North America. In England, some argue for 3-yearly screening while others believe 5-yearly screening is adequate, and the frequency varies from one part of the country to another. Screening histories of 1305 women aged 20–69 years, diagnosed with frankly invasive cervical cancer and 2532 age-matched controls were obtained from UK screening programme databases. Data were analysed in terms of time since last negative, and time since last screening smear. Five-yearly screening offers considerable protection (83%) against cancer at ages 55–69 years and even annual screening offers only modest additional protection (87%). Three-yearly screening offers additional protection (84%) over 5-yearly screening (73%) for cancers at ages 40–54 years, but is almost as good as annual screening (88%). In women aged 20–39 years, even annual screening is not as effective (76%) as 3-yearly screening in older women, and 3 years after screening cancer rates return to those in unscreened women. This calls into question the policy of having a uniform screening interval from age 20 to 64 years and stresses the value of screening in middle-aged women. More... »

PAGES

88-93

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974

DOI

http://dx.doi.org/10.1038/sj.bjc.6600974

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044836408

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12838306


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Policy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Audit", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical History Taking", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginal Smears", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sasieni", 
        "givenName": "P", 
        "id": "sg:person.01257735610.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257735610.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adams", 
        "givenName": "J", 
        "id": "sg:person.01116172313.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116172313.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.11485.39", 
          "name": [
            "Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cuzick", 
        "givenName": "J", 
        "id": "sg:person.01136740201.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136740201.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1996.196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056443386", 
          "https://doi.org/10.1038/bjc.1996.196"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-07-01", 
    "datePublishedReg": "2003-07-01", 
    "description": "While most experts agree that cervical screening is effective, there remains controversy over the most appropriate screening interval. Annual screening is common in North America. In England, some argue for 3-yearly screening while others believe 5-yearly screening is adequate, and the frequency varies from one part of the country to another. Screening histories of 1305 women aged 20\u201369 years, diagnosed with frankly invasive cervical cancer and 2532 age-matched controls were obtained from UK screening programme databases. Data were analysed in terms of time since last negative, and time since last screening smear. Five-yearly screening offers considerable protection (83%) against cancer at ages 55\u201369 years and even annual screening offers only modest additional protection (87%). Three-yearly screening offers additional protection (84%) over 5-yearly screening (73%) for cancers at ages 40\u201354 years, but is almost as good as annual screening (88%). In women aged 20\u201339 years, even annual screening is not as effective (76%) as 3-yearly screening in older women, and 3 years after screening cancer rates return to those in unscreened women. This calls into question the policy of having a uniform screening interval from age 20 to 64 years and stresses the value of screening in middle-aged women.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6600974", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "89"
      }
    ], 
    "keywords": [
      "annual screening", 
      "cervical screening", 
      "appropriate screening intervals", 
      "five-yearly screening", 
      "invasive cervical cancer", 
      "age-matched controls", 
      "middle-aged women", 
      "three-yearly screening", 
      "screening smears", 
      "unscreened women", 
      "screening interval", 
      "cervical cancer", 
      "Program database", 
      "cancer rates", 
      "age 40", 
      "older women", 
      "age 55", 
      "age 20", 
      "additional protection", 
      "UK audit", 
      "women", 
      "cancer", 
      "screening", 
      "considerable protection", 
      "most experts", 
      "years", 
      "different ages", 
      "smears", 
      "interval", 
      "age", 
      "history", 
      "protection", 
      "audit", 
      "evidence", 
      "controversy", 
      "control", 
      "database", 
      "benefits", 
      "time", 
      "rate", 
      "terms of time", 
      "UK", 
      "frequency", 
      "data", 
      "North America", 
      "countries", 
      "England", 
      "experts", 
      "part", 
      "values", 
      "questions", 
      "America", 
      "terms", 
      "policy"
    ], 
    "name": "Benefit of cervical screening at different ages: evidence from the UK audit of screening histories", 
    "pagination": "88-93", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044836408"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6600974"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12838306"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6600974", 
      "https://app.dimensions.ai/details/publication/pub.1044836408"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_377.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6600974"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600974'


 

This table displays all metadata directly associated to this object as RDF triples.

201 TRIPLES      21 PREDICATES      97 URIs      88 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6600974 schema:about N0eb928f7b4f94f5f990b5b96ec8654d2
2 N1ae69c1fa14d452b8ee3cf563f0db20a
3 N2138a51dc1a54f9cac9a842cef2b979d
4 N251aa83202a64f63ae9468f31aba137b
5 N28feb152ae914edfa0cb12499766efd0
6 N2f8e9c1a4398435aab999152cab1179d
7 N3e52766bc74a455e9a166667de1df137
8 N4831068e963642db94773392238aa6fd
9 N48d240aa5bf24d9da140a426dca78104
10 N4a2a7a682a5e41a89e5be78a9bcc55fe
11 N60a6b2ef7f014ca69a5019080a11999c
12 N70e8e760e9024ad2a589b1c3892634da
13 N73f6adc2ee7b4978a46608b814c90f57
14 N89c1a30a611340c79f03f3ebb58ed651
15 Nb2b09737dbf44a228b5ce247db139f08
16 Nd062ae85c98b401daf97ac47a6632d75
17 Ne003a9b526bf42f498c366420f5021b5
18 anzsrc-for:11
19 anzsrc-for:1117
20 schema:author N337a4f4dbf32466d85bf193c79ae0e88
21 schema:citation sg:pub.10.1038/bjc.1996.196
22 schema:datePublished 2003-07-01
23 schema:datePublishedReg 2003-07-01
24 schema:description While most experts agree that cervical screening is effective, there remains controversy over the most appropriate screening interval. Annual screening is common in North America. In England, some argue for 3-yearly screening while others believe 5-yearly screening is adequate, and the frequency varies from one part of the country to another. Screening histories of 1305 women aged 20–69 years, diagnosed with frankly invasive cervical cancer and 2532 age-matched controls were obtained from UK screening programme databases. Data were analysed in terms of time since last negative, and time since last screening smear. Five-yearly screening offers considerable protection (83%) against cancer at ages 55–69 years and even annual screening offers only modest additional protection (87%). Three-yearly screening offers additional protection (84%) over 5-yearly screening (73%) for cancers at ages 40–54 years, but is almost as good as annual screening (88%). In women aged 20–39 years, even annual screening is not as effective (76%) as 3-yearly screening in older women, and 3 years after screening cancer rates return to those in unscreened women. This calls into question the policy of having a uniform screening interval from age 20 to 64 years and stresses the value of screening in middle-aged women.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N3acbc39370954da1a8c679f7ba592cad
28 Nb2a9001b3df04aa68a9a827b49192516
29 sg:journal.1017082
30 schema:keywords America
31 England
32 North America
33 Program database
34 UK
35 UK audit
36 additional protection
37 age
38 age 20
39 age 40
40 age 55
41 age-matched controls
42 annual screening
43 appropriate screening intervals
44 audit
45 benefits
46 cancer
47 cancer rates
48 cervical cancer
49 cervical screening
50 considerable protection
51 control
52 controversy
53 countries
54 data
55 database
56 different ages
57 evidence
58 experts
59 five-yearly screening
60 frequency
61 history
62 interval
63 invasive cervical cancer
64 middle-aged women
65 most experts
66 older women
67 part
68 policy
69 protection
70 questions
71 rate
72 screening
73 screening interval
74 screening smears
75 smears
76 terms
77 terms of time
78 three-yearly screening
79 time
80 unscreened women
81 values
82 women
83 years
84 schema:name Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
85 schema:pagination 88-93
86 schema:productId N11f81240ef7d40e4b1611671cb284864
87 Nee2526a996f54d28b689950cab2a7229
88 Nf2d8fada074246c7b4d59bc2265e602b
89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044836408
90 https://doi.org/10.1038/sj.bjc.6600974
91 schema:sdDatePublished 2022-08-04T16:55
92 schema:sdLicense https://scigraph.springernature.com/explorer/license/
93 schema:sdPublisher Nd252ff8fb1d549c09d7e7306890e58b8
94 schema:url https://doi.org/10.1038/sj.bjc.6600974
95 sgo:license sg:explorer/license/
96 sgo:sdDataset articles
97 rdf:type schema:ScholarlyArticle
98 N0eb928f7b4f94f5f990b5b96ec8654d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Age Factors
100 rdf:type schema:DefinedTerm
101 N11f81240ef7d40e4b1611671cb284864 schema:name doi
102 schema:value 10.1038/sj.bjc.6600974
103 rdf:type schema:PropertyValue
104 N1ae69c1fa14d452b8ee3cf563f0db20a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Databases, Factual
106 rdf:type schema:DefinedTerm
107 N2138a51dc1a54f9cac9a842cef2b979d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Case-Control Studies
109 rdf:type schema:DefinedTerm
110 N251aa83202a64f63ae9468f31aba137b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Uterine Cervical Neoplasms
112 rdf:type schema:DefinedTerm
113 N28feb152ae914edfa0cb12499766efd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Medical Audit
115 rdf:type schema:DefinedTerm
116 N2f8e9c1a4398435aab999152cab1179d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Mass Screening
118 rdf:type schema:DefinedTerm
119 N337a4f4dbf32466d85bf193c79ae0e88 rdf:first sg:person.01257735610.85
120 rdf:rest Ncf021aa2e95d4686bc8151cb099a79af
121 N3acbc39370954da1a8c679f7ba592cad schema:issueNumber 1
122 rdf:type schema:PublicationIssue
123 N3e52766bc74a455e9a166667de1df137 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Middle Aged
125 rdf:type schema:DefinedTerm
126 N4831068e963642db94773392238aa6fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name United Kingdom
128 rdf:type schema:DefinedTerm
129 N48d240aa5bf24d9da140a426dca78104 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Health Policy
131 rdf:type schema:DefinedTerm
132 N4a2a7a682a5e41a89e5be78a9bcc55fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Practice Guidelines as Topic
134 rdf:type schema:DefinedTerm
135 N60a6b2ef7f014ca69a5019080a11999c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Female
137 rdf:type schema:DefinedTerm
138 N70e8e760e9024ad2a589b1c3892634da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Neoplasm Invasiveness
140 rdf:type schema:DefinedTerm
141 N73f6adc2ee7b4978a46608b814c90f57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Humans
143 rdf:type schema:DefinedTerm
144 N7faf071c1db44b3f8e79aa0fed91519d rdf:first sg:person.01136740201.43
145 rdf:rest rdf:nil
146 N89c1a30a611340c79f03f3ebb58ed651 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Medical History Taking
148 rdf:type schema:DefinedTerm
149 Nb2a9001b3df04aa68a9a827b49192516 schema:volumeNumber 89
150 rdf:type schema:PublicationVolume
151 Nb2b09737dbf44a228b5ce247db139f08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Adult
153 rdf:type schema:DefinedTerm
154 Ncf021aa2e95d4686bc8151cb099a79af rdf:first sg:person.01116172313.51
155 rdf:rest N7faf071c1db44b3f8e79aa0fed91519d
156 Nd062ae85c98b401daf97ac47a6632d75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Aged
158 rdf:type schema:DefinedTerm
159 Nd252ff8fb1d549c09d7e7306890e58b8 schema:name Springer Nature - SN SciGraph project
160 rdf:type schema:Organization
161 Ne003a9b526bf42f498c366420f5021b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Vaginal Smears
163 rdf:type schema:DefinedTerm
164 Nee2526a996f54d28b689950cab2a7229 schema:name pubmed_id
165 schema:value 12838306
166 rdf:type schema:PropertyValue
167 Nf2d8fada074246c7b4d59bc2265e602b schema:name dimensions_id
168 schema:value pub.1044836408
169 rdf:type schema:PropertyValue
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
174 schema:name Public Health and Health Services
175 rdf:type schema:DefinedTerm
176 sg:journal.1017082 schema:issn 0007-0920
177 1532-1827
178 schema:name British Journal of Cancer
179 schema:publisher Springer Nature
180 rdf:type schema:Periodical
181 sg:person.01116172313.51 schema:affiliation grid-institutes:grid.11485.39
182 schema:familyName Adams
183 schema:givenName J
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116172313.51
185 rdf:type schema:Person
186 sg:person.01136740201.43 schema:affiliation grid-institutes:grid.11485.39
187 schema:familyName Cuzick
188 schema:givenName J
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136740201.43
190 rdf:type schema:Person
191 sg:person.01257735610.85 schema:affiliation grid-institutes:grid.11485.39
192 schema:familyName Sasieni
193 schema:givenName P
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257735610.85
195 rdf:type schema:Person
196 sg:pub.10.1038/bjc.1996.196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056443386
197 https://doi.org/10.1038/bjc.1996.196
198 rdf:type schema:CreativeWork
199 grid-institutes:grid.11485.39 schema:alternateName Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK
200 schema:name Department of Epidemiology, Cancer Research UK, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, EC1M 6BQ, London, UK
201 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...